GlassScriptPhysician profile
Leah M Schmidt
NPI 1326692237
$1,977.18
in general payments reported to CMS, 2019-2025
14 companies · $99.22 in 2025
The $99.22 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $307 · 2022: $1,399 · 2023: $94.64 · 2024: $77.87 · 2025: $99.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $271.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $752.07 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $286.45 | 2021-2022 | |
| Glaxosmithkline, LLC. | $271.81 | 2021-2023 | Jemperli, Zejula |
| Atricure, INC. | $165.51 | 2022-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax, Epi-Ease Epicardial Access System |
| Seagen INC. | $148.06 | 2022-2023 | Tivdak |
| Clovis Oncology, INC. | $81.83 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $70.04 | 2022 | |
| Eisai INC. | $66.66 | 2021-2022 | |
| Janssen Biotech, INC. | $31.49 | 2025 | Tremfya |
| Myriad Genetic Laboratories, INC. | $27.42 | 2021-2022 | |
| Boston Scientific Corporation | $22.03 | 2022 | |
| Ethicon US, LLC | $21.67 | 2022 | |
| Abbvie INC. | $17.76 | 2021 | |
| Kci USA, INC. | $14.38 | 2023 | Activ.A.C. Ion Progress, V.A.C. Veraflo Cleanse Choice, Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leah Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.